Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Need better hair loss treatments beyond minoxidil, finasteride, and transplants.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Male hormones worsen kidney transplant damage, but blocking them helps.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Human hair varies widely and should be classified by curl type rather than race.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Eczema and fungal infections are the most common skin problems in Japan, with different age groups and genders affected by various conditions.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Premature hair graying in young men is linked to family history, obesity, and smoking.